Life

Health, science, climate, and society-focused reporting.

Biotech Sector Engages with Trump Amid M&A Surge

Smaller biotech firms are initiating discussions with the Trump administration as the sector experiences notable mergers and acquisitions, while addressing trust issues in healthcare.

Editorial Staff Apr 3

Life

100% Tariffs on Imported Brand-Name Drugs Announced by Trump Administration

The Trump administration has announced a 100% tariff on imported brand-name drugs, with significant caveats that may influence future trade negotiations.

Editorial Staff Apr 3

Life

World Autism Awareness Day: HHS Engages in Physical Activity Amid Policy Changes

On World Autism Awareness Day, the Department of Health and Human Services (HHS) marked the occasion with a workout, coinciding with significant policy shifts including a SCOTUS ruling on conversion therapy.

Editorial Staff Apr 3

Life

Patient Preference Highlights Trust Issues in Medical Therapies

A recent opinion piece discusses how patient preferences for peptide therapies over statins reflect broader trust issues in medical evidence.

Editorial Staff Apr 3

Life

Subscription Pricing for Lenacapavir: A Path to Enhanced Access and Cost Control

Lenacapavir has the potential to significantly impact HIV prevention. Implementing a subscription pricing model may facilitate broader access while managing costs effectively.

Editorial Staff Apr 3

Life

Supreme Court Ruling on Conversion Therapy Impacts Medical Authority

A recent Supreme Court decision regarding conversion therapy may limit the regulatory power of state medical boards over speech-related care, affecting medical practices.

Editorial Staff Apr 3

Life

CMS Reduces Star Ratings Measures, Allocates $18.6 Billion to Medicare Advantage Plans

The Centers for Medicare & Medicaid Services (CMS) is reducing the number of metrics used to evaluate health insurers, resulting in an additional $18.6 billion for Medicare Advantage plans.

Editorial Staff Apr 2

Life

EPA Targets Microplastics in Drinking Water Contaminants Study

The EPA has identified microplastics as a potential contaminant in drinking water, reflecting growing concerns over water quality and safety.

Editorial Staff Apr 2

Life

Small Drug Manufacturers Engage in Pricing Negotiations Amid Tariff Concerns

The Trump administration is negotiating new drug-pricing agreements with smaller pharmaceutical companies, influenced by potential tariffs.

Editorial Staff Apr 2

Life

Trump's 100% Tariffs on Brand-Name Drugs: Implications for Pharmaceutical Manufacturing

The recent announcement of 100% tariffs on brand-name drugs aims to reshape the pharmaceutical landscape, focusing on domestic manufacturing.

Editorial Staff Apr 2

Life

FDA Decisions on Rare Disease Drugs Influence Biotech Investment Trends

Recent FDA decisions regarding rare disease medications are shaping investment dynamics in the biotech sector, while Eli Lilly diversifies into sleep medicine.

Editorial Staff Apr 2

Life

FDA's Criteria for 'Breakthrough' Devices: An Analysis of AI-Powered Innovations

The FDA's evolving criteria for 'breakthrough' device designation is examined, focusing on AI-powered technologies and their implications for medical infrastructure.

Editorial Staff Apr 2

Life

Potential Health Care Cuts Impacting Congressional Reconciliation Efforts

Proposed reductions in health care spending could complicate ongoing Congressional negotiations aimed at funding immigration enforcement.

Editorial Staff Apr 2

Life

Lilly Launches Oral GLP-1 Obesity Treatment Amid Market Dynamics

Lilly has introduced its oral GLP-1 obesity medication, prompting a strategic response from Novo Nordisk. This development may influence drug pricing and market competition.

Editorial Staff Apr 2

Life

Trump Administration's Proposed 100% Tariff on Patented Medicines

The FDA's recent approval of a new obesity treatment from Lilly coincides with the Trump administration's plans for a significant tariff on certain patented drugs.

Editorial Staff Apr 2

Life

Health Care's Influence on the 2026 Midterm Elections: An Analytical Overview

As the 2026 midterm elections approach, a KFF issue brief highlights the historical significance of health care in elections and its anticipated role in shaping voter priorities.

Editorial Staff Apr 2

Life

Debate Over Proposed 'Preclinical Obesity' Diagnosis Highlights Systemic Challenges

The introduction of a 'preclinical obesity' diagnosis seeks to refine obesity definitions. However, experts caution it may complicate treatment access and exacerbate existing health inequities.

Editorial Staff Apr 2

Life

CDC Halts Testing for Rabies and Pox Viruses: Implications for Public Health Infrastructure

The CDC's decision to cease testing for rabies and pox viruses raises significant concerns regarding public health monitoring and response capabilities.

Editorial Staff Apr 2

Life

Analysis of 'Takeover Tuesday' Impact on Biotech Sector Performance

The recent phenomenon known as 'Takeover Tuesday' has significantly influenced the biotech sector's quarterly performance, highlighting key trends in mergers and acquisitions.

Editorial Staff Apr 2

Life

Evaluating FDA Breakthrough Designation for AI Medical Devices

An analysis highlights the FDA's preference for AI-powered medical devices that address multiple challenges, indicating a shift in regulatory focus.

Editorial Staff Apr 2